Parallel Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-5,536
| Closed | -$132K | – | 2780 |
|
|
2019
Q4 | $132K | Sell |
5,536
-655
| -11% | -$15.6K | 0.01% | 663 |
|
|
2019
Q3 | $166K | Buy |
6,191
+725
| +13% | +$19.4K | 0.01% | 537 |
|
|
2019
Q2 | $148K | Sell |
5,466
-300
| -5% | -$8.12K | 0.01% | 524 |
|
|
2019
Q1 | $200K | Buy |
5,766
+1,125
| +24% | +$39K | 0.02% | 396 |
|
|
2018
Q4 | $90K | Buy |
4,641
+2,891
| +165% | +$56.1K | 0.01% | 577 |
|
|
2018
Q3 | $47K | Buy |
1,750
+1,450
| +483% | +$38.9K | 0.01% | 841 |
|
|
2018
Q2 | $11K | Hold |
300
| – | – | ﹤0.01% | 1321 |
|
|
2018
Q1 | $10K | Hold |
300
| – | – | ﹤0.01% | 1296 |
|
|
2017
Q4 | $15K | Hold |
300
| – | – | ﹤0.01% | 1140 |
|
|
2017
Q3 | $15K | Hold |
300
| – | – | ﹤0.01% | 1130 |
|
|
2017
Q2 | $19K | Hold |
300
| – | – | ﹤0.01% | 1038 |
|
|
2017
Q1 | $12K | Buy |
+300
| New | +$12K | ﹤0.01% | 1164 |
|